Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden

Arthritis Research and Therapy

Volumn 13, Issue 1, 2011, Pages

  Eriksson, Catharina ^a   Kokkonen, Heidi ^a   Johansson, Martin ^a   Hallmans, Göran ^a   Wadell, Göran ^a   Rantapää Dahlqvist, Solbritt ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CELL NUCLEUS ANTIGEN; CENTROMERE PROTEIN B; DOUBLE STRANDED DNA; DOUBLE STRANDED DNA ANTIBODY; HISTIDINE TRANSFER RNA LIGASE; HISTONE; RIBONUCLEOPROTEIN; SJOGREN SYNDROME ANTIGEN; SJOGREN SYNDROME ANTIGEN B; SM ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIGEN;

ADULT; ANTIBODY SCREENING; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INFLAMMATION; MALE; SENSITIVITY AND SPECIFICITY; SKIN MANIFESTATION; SWEDEN; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; BLOOD; CASE CONTROL STUDY; EARLY DIAGNOSIS; IMMUNOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; AUTOANTIGENS; CASE-CONTROL STUDIES; EARLY DIAGNOSIS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SWEDEN; YOUNG ADULT;

EID: 79951800941     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3258     Document Type: Article

References (35)

1. Arbuckle MR, James JA, Dennis GJ, Rubertone MV, McClain MT, Kim XR, Harley JB. Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus. Lupus 2003, 12:99-106. 10.1191/0961203303lu334oa, 12630753.
2. Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 9:A277-A287. 10.1016/j.autrev.2009.12.008, 20036343.
3. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003, 349:1526-1533. 10.1056/NEJMoa021933, 14561795.
4. Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM, Tarp U, Poulsen LH, van Overeem Hansen G, Skaarup B, Hansen TM, Podenphant J, Halberg P. A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol 1998, 17:468-477. 10.1007/BF01451282, 9890674.
5. Arbuckle MR, James JA, Kohlhase KF, Rubertone MV, Dennis GJ, Harley JB. Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scand J Immunol 2001, 54:211-219. 10.1046/j.1365-3083.2001.00959.x, 11439169.
6. Heinlen LD, McClain MT, Merrill J, Akbarali YW, Edgerton CC, Harley JB, James JA. Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis Rheum 2007, 56:2344-2351. 10.1002/art.22665, 17599763.
7. Danieli MG, Fraticelli P, Salvi A, Gabrielli A, Danieli G. Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. Clin Rheumatol 1998, 17:195-201. 10.1007/BF01451046, 9694051.
8. Batstra MR, Aanstoot HJ, Herbrink P. Prediction and diagnosis of type 1 diabetes using β-cell autoantibodies. Clin Lab 2001, 47:497-507.
9. LaGasse JM, Brantley MS, Leech NJ, Rowe RE, Monks S, Palmer JP, Nepom GT, McCulloch DK, Hagopian WA. Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study. Diabetes Care 2002, 25:505-511. 10.2337/diacare.25.3.505, 11874938.
10. Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003, 48:2741-2749.
11. Aho K, Heliovaara M, Maatela J, Tuomi T, Palosuo T. Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol 1991, 18:1282-1284.
12. Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994, 120:544-551.
13. Isenberg DA, Hammond L, Fisher C, Griffiths M, Stewart J, Bottazzo GF. Predictive value of SS-B precipitating antibodies in Sjögren's syndrome. Br Med J (Clin Res Ed) 1982, 284:1738-1740. 10.1136/bmj.284.6331.1738, 1498670, 6805691.
14. Scofield RH, Kaufman KM, Baber U, James JA, Harley JB, Kurien BT. Immunization of mice with human 60-kd Ro peptides results in epitope spreading if the peptides are highly homologous between human and mouse. Arthritis Rheum 1999, 42:1017-1024. 10.1002/1529-0131(199905)42:5<1017::AID-ANR22>3.0.CO;2-7, 10323459.
15. Aho K, Koskela P, Makitalo R, Heliovaara M, Palosuo T. Antinuclear antibodies heralding the onset of systemic lupus erythematosus. J Rheumatol 1992, 19:1377-1379.
16. McClain MT, Arbuckle MR, Heinlen LD, Dennis GJ, Roebuck J, Rubertone MV, Harley JB, James JA. The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis Rheum 2004, 50:1226-1232. 10.1002/art.20120, 15077305.
17. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277. 10.1002/art.1780251101, 7138600.
18. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725. 10.1002/art.1780400928, 9324032.
19. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972, 52:148-159. 10.1016/0002-9343(72)90064-2, 4621694.
20. Heinlen LD, McClain MT, Ritterhouse LL, Bruner BF, Edgerton CC, Keith MP, James JA, Harley JB. 60 kD Ro and nRNP A frequently initiate human lupus autoimmunity. PLoS One 2010, 5:e9599. 10.1371/journal.pone.0009599, 2835743, 20224770.
21. Tench CM, Isenberg DA. The variation in anti-ENA characteristics between different ethnic populations with systemic lupus erythematosus over a 10-year period. Lupus 2000, 9:374-376. 10.1191/096120300678828451, 10878731.
22. Arnett FC, Hamilton RG, Roebber MG, Harley JB, Reichlin M. Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus. J Rheumatol 1988, 15:1773-1776.
23. Wang J, Satoh M, Kabir F, Shaw M, Domingo MA, Mansoor R, Behney KM, Dong X, Lahita RG, Richards HB, Reeves WH. Increased prevalence of autoantibodies to ku antigen in African American versus white patients with systemic lupus erythematosus. Arthritis Rheum 2001, 44:2367-2370. 10.1002/1529-0131(200110)44:10<2367::AID-ART400>3.0.CO;2-I, 11665978.
24. Lau CS, Yin G, Mok MY. Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus 2006, 15:715-719. 10.1177/0961203306072311, 17153840.
25. Ruffatti A, Rossi L, Calligaro A, Del Ross T, Lagni M, Marson P, Todesco S. Autoantibodies of systemic rheumatic diseases in the healthy elderly. Gerontology 1990, 36:104-111. 10.1159/000213183, 2376330.
26. Juby AG, Davis P, McElhaney JE, Gravenstein S. Prevalence of selected autoantibodies in different elderly subpopulations. Br J Rheumatol 1994, 33:1121-1124. 10.1093/rheumatology/33.12.1121, 8000738.
27. Deshmukh US, Gaskin F, Lewis JE, Kannapell CC, Fu SM. Mechanisms of autoantibody diversification to SLE-related autoantigens. Ann N Y Acad Sci 2003, 987:91-98. 10.1111/j.1749-6632.2003.tb06036.x, 12727627.
28. Monneaux F, Muller S. Epitope spreading in systemic lupus erythematosus: identification of triggering peptide sequences. Arthritis Rheum 2002, 46:1430-1438. 10.1002/art.10263, 12115171.
29. Poole BD, Schneider RI, Guthridge JM, Velte CA, Reichlin M, Harley JB, James JA. Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus. Arthritis Rheum 2009, 60:848-859. 10.1002/art.24306, 2653589, 19248110.
30. de Vlam K, De Keyser F, Verbruggen G, Vandenbossche M, Vanneuville B, D'Haese D, Veys EM. Detection and identification of antinuclear autoantibodies in the serum of normal blood donors. Clin Exp Rheumatol 1993, 11:393-397.
31. Myckatyn SO, Russell AS. Outcome of positive antinuclear antibodies in individuals without connective tissue disease. J Rheumatol 2003, 30:736-739.
32. Mahler M, Silverman ED, Schulte-Pelkum J, Fritzler MJ. Anti-Scl-70 (topo-I) antibodies in SLE: myth or reality?. Autoimmun Rev 9:756-760. 10.1016/j.autrev.2010.06.005, 20601198.
33. Hanly JG, Thompson K, McCurdy G, Fougere L, Theriault C, Wilton K. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus. J Immunol Methods 2010, 352:147-152. 10.1016/j.jim.2009.10.003, 19836394.
34. Freemer MM, King TE, Criswell LA. Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus. Ann Rheum Dis 2006, 65:581-584. 10.1136/ard.2005.039438, 1798144, 16150789.
35. Klareskog L, Alfredsson L, Rantapää-Dahlqvist S, Berglin E, Stolt P, Padyukov L. What precedes development of rheumatoid arthritis?. Ann Rheum Dis 2004, 63(Suppl 2):ii28-ii31. 10.1136/ard.2004.028225, 1766766, 15479868.